BioCryst (BCRX) Q3 2026 Earnings Call Transcript
Guidance rose as cost cuts from site closures started to take hold.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
More in Finance & Markets
The SPAC Sponsor Behind Lucid and Oklo Is Taking Agility Robotics Public on Nov. 5. Here's What Those 2 Stocks Did in Their First 90 Days.
The robotics stock could see wild swings after its public debut.
- Agility Robotics to go public on November 5th via merger with CCXI
- Lucid, another Churchill Capital-backed company, saw stock drop to $3.50
- Oklo rebounded to $23 with major contracts, suggesting potential for Agility
Revolut’s Valuation Hits $115 Billion With New Funding
Revolut’s valuation has climbed to $115 billion with its latest round of funding. The U.K. FinTech announced the figure Wednesday (Nov.
The Democrats Just Took Back the House and Senate. Here's What That Could Mean For Crypto Regulation in 2027.
President Trump has been a pro-crypto advocate during his second term.
- Democrats secured control of House and Senate in recent midterm elections.
- Analysts predict impact on crypto regulation in 2027.
- Democrats may investigate Trump's ties to crypto, potentially delaying Clarity Act.
Criteo (CRTO) Q3 2026 Earnings Call Transcript
Enterprise pullbacks weighed on results as CTV and AI channels gained ground.
Marvell's Deal to Acquire Lumentum Could Be a Game Changer for the Stock
Marvell's acquisition of Lumentum will create an optical networking juggernaut.
Cerenome Unit Signs National Reimbursement Agreement With Aetna; Shares Fall
(RTTNews) - Biotechnology company Cerenome, Inc. (CNSY) announced on Wednesday that its CNSide Diagnostics unit has entered into a national in-network laboratory provider agreement with Aetna covering…